Abzena (ABZA LN) Halozyme terminates agreement, no impact on outlook or valuation | Applied Graphene Materials (AGM LN) Signs of increasing commercial momentum | EKF Diagnostics (EKF LN) FDA 501k/CLIA Waiver for DiaSpect Tm | Elektron Technology (EKT LN) Growth milestone for Checkit | LiDCO Group (LID LN) Disruptive model gaining traction | The PRS REIT (PRSR LN) Q3: Maintained trajectory, new construction partner
10 Apr 2018
Morning Song
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
- Published:
10 Apr 2018 -
Author:
N+1 Singer Team -
Pages:
13
Abzena (ABZA LN) Halozyme terminates agreement, no impact on outlook or valuation | Applied Graphene Materials (AGM LN) Signs of increasing commercial momentum | EKF Diagnostics (EKF LN) FDA 501k/CLIA Waiver for DiaSpect Tm | Elektron Technology (EKT LN) Growth milestone for Checkit | LiDCO Group (LID LN) Disruptive model gaining traction | The PRS REIT (PRSR LN) Q3: Maintained trajectory, new construction partner